Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Promoting return of function in multiple sclerosis: An integrated approach.
Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Acute Disseminated Encephalomyelitis: The Time Until Diagnosis and Its Subsequent Course in Children.
Neurodegeneration and inflammation in MS: The eye teaches us about the storm.
The brain microvascular endothelium supports T cell proliferation and has potential for alloantigen presentation.
[Neurodegeneration in multiple sclerosis and the neuroprotective effect of glatiramer acetate: a literature review].
Feature Selection in Order to Extract Multiple Sclerosis Lesions Automatically in 3D Brain Magnetic Resonance Images Using Combination of Support Vector Machine and Genetic Algorithm.
New extension study data with Novartis drug Gilenya® shows patients successfully treated for up to 7 years in relapsing MS
Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Dynamics of oligodendrocyte generation and myelination in the human brain.
A flexible mixed-effect negative binomial regression model for detecting unusual increases in MRI lesion counts in individual multiple sclerosis patients.
(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
The top clinical trial opportunities in therapeutic apheresis and neurology.
CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Care ethics for guiding the process of multiple sclerosis diagnosis.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Association of methylenetetrahydrofolate reductase A1298C polymorphism but not of C677T with multiple sclerosis in Tunisian patients.
Early White Matter Changes in Childhood Multiple Sclerosis: A Diffusion Tensor Imaging Study.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
NG2, a common denominator for neuroinflammation, blood-brain barrier alteration, and oligodendrocyte precursor response in EAE, plays a role in dendritic cell activation.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »